Project documents | Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Equality Impact Assessment (Guidance development) (PDF 130 KB)

Published:

21 July 2021
Final scope (PDF 219 KB)

Published:

21 July 2021
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 370 KB)

Published:

21 July 2021
Final stakeholder list (PDF 163 KB)

Published:

21 July 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 221 KB)

Published:

25 November 2020
Draft matrix post referral (PDF 163 KB)

Published:

30 November 2020